239 related articles for article (PubMed ID: 10588772)
1. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole.
Richter J; Freise S; Mull R; Millán JC
Trop Med Int Health; 1999 Nov; 4(11):774-81. PubMed ID: 10588772
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
Millán JC; Mull R; Freise S; Richter J;
Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
[TBL] [Abstract][Full Text] [Related]
3. Fasciola hepatica-a "Diver" in the Biliary Tree.
Martins A; Gonçalves Á; Almeida T; Lopes L; Midões A
J Gastrointest Surg; 2017 Nov; 21(11):1959-1960. PubMed ID: 28634648
[TBL] [Abstract][Full Text] [Related]
4. Clinical presentation and management of Fasciola hepatica infection: single-center experience.
Kaya M; Beştaş R; Cetin S
World J Gastroenterol; 2011 Nov; 17(44):4899-904. PubMed ID: 22171131
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic imaging in the study of human hepatobiliary fascioliasis.
Cantisani V; Cantisani C; Mortelé K; Pagliara E; D'Onofrio M; Fernandez M; D'Ambrosio U; Lombardi V; Marigliano C; Ricci P
Radiol Med; 2010 Feb; 115(1):83-92. PubMed ID: 20012922
[TBL] [Abstract][Full Text] [Related]
6. Apparent triclabendazole-resistant human Fasciola hepatica infection, the Netherlands.
Winkelhagen AJ; Mank T; de Vries PJ; Soetekouw R
Emerg Infect Dis; 2012 Jun; 18(6):1028-9. PubMed ID: 22607719
[No Abstract] [Full Text] [Related]
7. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
Yilmaz B; Köklü S; Gedikoglu G
Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
[TBL] [Abstract][Full Text] [Related]
8. Living Fasciola hepatica in biliary tree: a case report.
Aminian K; Rezayat KA; Shafaghi A; Tanhaeevash R
Ann Hepatol; 2012; 11(3):395-8. PubMed ID: 22481460
[TBL] [Abstract][Full Text] [Related]
9. [Fasciola hepatica infection. Successful therapy using triclabendazole].
Markwalder K; Koller M; Goebel N; Wolff K
Schweiz Med Wochenschr; 1988 Jul; 118(27-28):1048-52. PubMed ID: 3413464
[TBL] [Abstract][Full Text] [Related]
10. A clinical presentation of a very rare infection: parenchymal Fasciola hepatica.
Sapmaz F; Kalkan IH; Guliter S; Nazlıoğlu A
Turkiye Parazitol Derg; 2013; 37(4):305-6. PubMed ID: 24412878
[TBL] [Abstract][Full Text] [Related]
11. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma.
Şenateş E; Doğan A; Şenates BE; Bodakçi E; Bekçibasi M
Infez Med; 2014 Dec; 22(4):313-6. PubMed ID: 25551848
[TBL] [Abstract][Full Text] [Related]
12. Treatment Failure after Multiple Courses of Triclabendazole among Patients with Fascioliasis in Cusco, Peru: A Case Series.
Cabada MM; Lopez M; Cruz M; Delgado JR; Hill V; White AC
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004361. PubMed ID: 26808543
[TBL] [Abstract][Full Text] [Related]
13. Treatment of human chronic fascioliasis with triclabendazole: drug efficacy and serologic response.
Apt W; Aguilera X; Vega F; Miranda C; Zulantay I; Perez C; Gabor M; Apt P
Am J Trop Med Hyg; 1995 Jun; 52(6):532-5. PubMed ID: 7611560
[TBL] [Abstract][Full Text] [Related]
14. Biliary obstruction caused by the liver fluke, Fasciola hepatica.
Ishikawa T; Meier-Stephenson V; Heitman SJ
CMAJ; 2016 Apr; 188(7):524-526. PubMed ID: 26728843
[No Abstract] [Full Text] [Related]
15. The efficacy of triclabendazole (Fasinex) against immature and adult Fasciola hepatica in experimentally infected cattle.
Shi FH; Lin BF; Qian CG; Li M; Fang MB; Ma JL; Shen W; Wang SW; Jian XL
Vet Parasitol; 1989 Sep; 33(2):117-24. PubMed ID: 2800300
[TBL] [Abstract][Full Text] [Related]
16. [Distomatosis of the bile ducts. Value of retrograde cholangiography. Efficacy of triclabendazole].
De Ronde T; Mélange M; Van Beers B; Trigaux JP; Dive C; Lecaillon JB; Poltera AA
Acta Clin Belg; 1992; 47(3):209-14. PubMed ID: 1332351
[TBL] [Abstract][Full Text] [Related]
17. Resistance of Fasciola hepatica to triclabendazole.
Overend DJ; Bowen FL
Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
[No Abstract] [Full Text] [Related]
18. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
Graham CS; Brodie SB; Weller PF
Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
[TBL] [Abstract][Full Text] [Related]
19. US-guided gallbladder aspiration: a new diagnostic method for biliary fascioliasis.
Kabaalioglu A; Apaydin A; Sindel T; Lüleci E
Eur Radiol; 1999; 9(5):880-2. PubMed ID: 10369983
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
